Altana To Sue Generics Maker Over Protonix ANDA
An unnamed drugmaker is challenging Altana's patents on Protonix with the U.S. Food and Drug Administration, Altana said.
"Altana will, together with its American partner Wyeth, take all necessary legal steps against any imitator," Altana Chief Executive Hans-Joachim Lohrisch said in a statement.
Marketed with Wyeth in the U.S. as Protonix, the...
To view the full article, register now.